The X-linked inhibitor of apoptosis protein enhances survival of murine islet allografts

Diabetes

Volumn 54, Issue 9, 2005, Pages 2533-2540

  Plesner, Annette ^a   Liston, Peter ^b   Tan, Rusung ^a   Korneluk, Robert G ^b   Verchere, C Bruce ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^b CHILDREN S HOSPITAL OF EASTERN ONTARIO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CELL VIABILITY; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GRAFT SURVIVAL; HELA CELL; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PANCREAS ISLET CELL; PANCREAS ISLET TRANSPLANTATION; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; APOPTOSIS; BLOOD GLUCOSE; DIABETES MELLITUS, EXPERIMENTAL; GENE EXPRESSION; ISLETS OF LANGERHANS; ISLETS OF LANGERHANS TRANSPLANTATION; MICE; MICE, INBRED BALB C; MICE, INBRED CBA; TRANSFORMATION, GENETIC;

EID: 24144447290     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.54.9.2533     Document Type: Article

References (39)

1. Hering B: Insulin independence following islet transplantation in man: a comparison of different recipient categories. Int Islet Tranpl Registry 6:5-19, 1996
2. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, Kneteman NM, Rajotte RV: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238, 2000
3. Ryan EA, Lakey JR, Rajotte RV, Korbutt GS, Kin T, Imes S, Rabinovitch A, Elliott JF, Bigam D, Kneteman NM, Warnock GL, Larsen I, Shapiro AM: Clinical outcomes and insulin secretion after islet transplantation with the Edmonton Protocol. Diabetes 50:710-719, 2001
4. Diamond AS, Gill RG: An essential contribution by IFN-γ to CD8+ T cell-mediated rejection of pancreatic islet allografts. J Immunol 165:247-255, 2000
5. Ahmed KR, Guo TB, Gaal KK: Islet rejection in perforin-deficient mice: the role of perforin and Fas. Transplantation 63:951-957, 1997
6. Mathis D, Vence L, Benoist C: Beta-cell death during progression to diabetes. Nature 414:792-798, 2001
7. Nicolls MR, Coulombe M, Gill RG: The basis of immunogenicity of endocrine allografts. Crit Rev Immunol 21:87-101, 2001
8. Lacy PE, Scharp DW: Islet transplantation in treating diabetes. Annu Rev Med 37:33-40, 1986
9. Holcik M, Gibson H, Korneluk RG: XIAP: apoptotic brake and promising therapeutic target. Apoptosis 6:253-261, 2001
10. Salvesen GS, Duckett CS: IAP proteins: blocking the road to death's door. Nat Rev Mol Cell Biol 3:401-410, 2002
11. Xu D, Bureau Y, McIntyre DC, Nicholson DW, Liston P, Zhu Y, Fong WG, Crocker SJ, Korneluk RG, Robertson GS: Attenuation of ischemia-induced cellular and behavioral deficits by X chromosome-linked inhibitor of apoptosis protein overexpression in the rat hippocampus. J Neurosci 19:5026-5033, 1999
12. Kugler S, Straten G, Kreppel F, Isenmann S, Liston P, Bahr M: The X-linked inhibitor of apoptosis (XIAP) prevents cell death in axotomized CNS neurons in vivo. Cell Death Differ 7:815-824, 2000
13. Perrelet D, Ferri A, Liston P, Muzzin P, Korneluk RG, Kato AC: IAPs are essential for GDNF-mediated neuroprotective effects in injured motor neurons in vivo. Nat Cell Biol 4:175-179, 2002
14. McKinnon SJ, Lehman DM, Tahzib NG, Ransom NL, Reitsamer HA, Liston P, LaCasse E, Li Q, Korneluk RG, Hauswirth WW: Baculoviral IAP repeat-containing-4 protects optic nerve axons in a rat glaucoma model. Mol Ther 5:780-787, 2002
15. Crocker SJ, Liston P, Anisman H, Lee CJ, Smith PD, Earl N, Thompson CS, Park DS, Korneluk RG, Robertson GS: Attenuation of MPTP-induced neurotoxicity and behavioural impairment in NSE-XIAP transgenic mice. Neurobiol Dis 12:150-161, 2003
16. Robertson GS, Crocker SJ, Nicholson DW, Schulz JB: Neuroprotection by the inhibition of apoptosis. Brain Pathol 10:283-292, 2000
17. O'Brien T, Karlsen AE, Andersen HU, Mandrup-Poulsen T, Nerup J: Absence of toxicity associated with adenoviral-mediated transfer of the beta-galactosidase reporter gene to neonatal rat islets in vitro. Diabetes Res Clin Prac 44:157-163, 1999
18. Gotoh M, Maki T, Kiyoizumi T, Satomi S, Monaco AP: An improved method for isolation of mouse pancreatic islets. Transplantation 40:437-438, 1985
19. Verchere CB, D'Alessio DA, Prigeon RL, Hull RL, Kahn SE: The constitutive secretory pathway is a major route for islet amyloid polypeptide secretion in neonatal but not adult rat islet cells. Diabetes 49:1477-1484, 2000
20. Fong WG, Liston P, Rajcan-Separovic E, St Jean M, Craig C, Korneluk RG: Expression and genetic analysis of XIAP-associated factor 1 (XAF1) in cancer cell lines. Genomics 70:113-122, 2000
21. Stegall MD, Dean PG, Ninova D, Cohen AJ, Shepard GM, Gup C, Gill RG: alpha4 integrin in islet allograft rejection. Transplantation 71:1549-1555, 2001
22. Carter BZ, Milella M, Tsao T, McQueen T, Schoeber WD, Hu W, Dean NM, Steelman L, McCubrey JA, Andreeff M: Regulation and targeting of antiapoptotic XIAP in acute myeloid leukemia. Leukemia 17:2081-2089, 2003
23. Hu Y, Cherton-Horvat G, Dragowska V, Baird S, Korneluk RG, Dukin JP, Mayer LD, LaCasse EC: Antisense oligonucleotides targeting XIAP induce apoptosis and enhance chemotherapeutic activity against human lung cancer cells in vitro and in vivo. Clin Cancer Res 9:2826-2836, 2003
24. Bilim V, Kasahara T, Hara N, Takahashi K, Tomita Y: Role of XIAP in malignant phenotype of transitional cell cancer (TCC) and therapeutic activity of XIAP antisense oligonucleotides against multidrug-resistant TCC in vitro. Int J Cancer 103:29-37, 2003
25. Hui H, Khoury N, Zhao X, Balkir L, D'Amico E, Bullotta A, Nguyen E, A G, R. P: Adenovirus-mediated XIAP gene transfer reverses the negative effects of immunosuppressive drugs on insulin secretion and cell viability of isolated human islets. Diabetes 54:424-433, 2005
26. Eizirik DL, Manrup-Poulsen T: A choice of death: the signal-transduction of immune-mediated beta-cell apoptosis. Diabetologia 44:2115-2133, 2001
27. Mandrup-Poulsen T: Beta cell death and protection. Ann N Y Acad Sci 1005:32-42, 2003
28. Matzinger P: The danger model: a renewed sense of self. Science 296:301-305, 2002
29. Montgomery SP, Hale DA, Hirshberg B, Harlan DM, Kirk AD: Preclinical evaluation of tolerance induction protocols and islet transplantation in non-human primates. Immunol Rev 183:214-222, 2001
30. Li XC, Ima A, Li Y, Zheng XX, Malek TR, Strom TB: Blocking the common gamma-chain of cytokine receptors induces T cell apoptosis and long-term islet allograft survival. J Immunol 164:1193-1199, 2000
31. Barrou B, Bertry-Coussot L, Morin S, Sainz J, Lucas B, Bitker MO, Debre P, Lemarchand P: Prolonged islet allograft survival by adenovirus-mediated transfer of sICAM-1/Ig immunoadhesin gene. Human Gene Ther 13:1441-1450, 2002
32. Laumonier T, Potiron N, Boeffard F, Chagneau C, Brouard S, Guillot C, Soulillou JP, Anegon I, Le Mauff B: CTLA4Ig adenoviral gene transfer induces long-term islet rat allograft survival, without tolerance, after systemic but not local intragraft expression. Human Gene Ther 14:561-575, 2003
33. Luo Z, Gotoh M, Grochowiecki T, Tanaka T, Kimura F, Kawashima H, Yagita H, Okumura K, Miyasaka M: Anergic T cells generated in vitro suppress rejection response to islet allografts. Transplantation 69:2144-2148, 2000
34. Opara EC, Kendall WF Jr: Immunoisolation techniques for islet cell transplantation. Expert Opin Biol Ther 2:503-511, 2002
35. Kin T, Rajotte RV, Dufour JM, Korbutt GS: Development of an immuno-privileged site to prolong islet allograft survival. Cell Transplant 11:547-552, 2002
36. Contreras JL, Bilbao G, Smyth CA, Eckhoff DE, Jiang XL, Jenkins S, Thomas FT, Curiel DT, Thomas JM: Cytoprotection of pancreatic islets before and early after transplantation using gene therapy. Kidney Int Suppl 61:79-84, 2002
37. Bertera S, Crawford ML, Alexander AM, Papworth GD, Watkins SC, Robbins PD, Trucco M: Gene transfer of manganese superoxide dismutase extends islet graft function in a mouse model of autoimmune diabetes. Diabetes 52:387-393, 2003
38. Pericin M, Althage A, Freigang S, Hengartner H, Rolland E, Dupraz P, Thorens B, Aebischer P, Zinkernagel RM: Allogeneic beta-islet cells correct diabetes and resist immune rejection. Proc Natl Acad Sci U S A 99:8203-8206, 2002
39. Grey ST, Longo C, Shukri T, Patel VI, Csizmadia E, Daniel S, Arvelo MB, Tchipashvili V, Ferran C: Genetic engineering of a suboptimal islet graft with A20 preserves β cell mass and function. J Immunol 170:6250-6256, 2003